Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

Unlocking the money-making potential of RNAi

Nature Biotechnology volume 21, pages 1441–1446 (2003)Cite this article

Bigger than monoclonal antibodies? More powerful than antisense? Biotech investors say...maybe.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Estimated annual worldwide revenues from RNAi and market segments.
Figure 2: siRNA discovery timeline.
Figure 3: Inhibition of hepatitis B virus in mice by RNAi.
Figure 4: Inhibition by siRNA of neovascularization in a mouse model of age-related macular degeneration (AMD).

References

  1. Front Line Strategic Consulting. siRNA: A Strategic Market Outlook and Business Analysis (Front Line Strategic Consulting, San Mateo, CA, USA, February 2003).

  2. McCaffrey, A.P. et al. Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol. 21, 639–644 (2003).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. freelance writer based, San Francisco, California, USA

    Ken Howard

Authors
  1. Ken Howard
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Howard, K. Unlocking the money-making potential of RNAi. Nat Biotechnol 21, 1441–1446 (2003). https://doi.org/10.1038/nbt1203-1441

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1203-1441

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing